Pfizer Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Patient Information Leaflet last updated on the eMC: 15/07/2010
PIL Epanutin 30mg/5ml Oral Suspension

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 15/07/2010 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
  • Change to MA holder contact details
Updated on 28/05/2010 and displayed until 15/07/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 24/07/2009 and displayed until 28/05/2010
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to date of revision
  • Correction of spelling/typing errors
Updated on 28/01/2009 and displayed until 24/07/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 20/01/2009 and displayed until 28/01/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change due to user-testing of patient information
Updated on 24/12/2008 and displayed until 20/01/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 22/09/2008 and displayed until 24/12/2008
Reasons for adding or updating:
  • Change of manufacturer
Updated on 23/01/2008 and displayed until 22/09/2008
Reasons for adding or updating:
  • Change to name of manufacturer
Updated on 07/11/2005 and displayed until 23/01/2008
Reasons for adding or updating:
  • Change of trade or generic name
  • Change of licence holder
  • Change to drug interactions
  • Change to warnings or special precautions for use
  • Change to, or new, use for medicine
  • Change to dosage and administration
  • Change to side-effects
  • Change to storage instructions
  • Change to date of revision
Updated on 16/02/2004 and displayed until 07/11/2005
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   phenytoin